Invacare reported $47.98M in Gross Profit on Sales for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Abiomed ABMD:US USD 217.04M 7.48M
Accuray ARAY:US USD 34.6M 8.42M
Atricure ATRC:US USD 61.71M 1.81M
Baxter International BAX:US USD 1.15B 310M
Boston Scientific BSX:US USD 2.18B 42M
Cardiovascular Systems CSII:US USD 42.98M 3.25M
Cooper Companies COO:US USD 552.1M 19.6M
Cryolife CRY:US USD 48.74M 3.43M
Fisher Paykel Healthcare FPH:NZ NZD 485M 82.7M
Getinge GETIB:SS SEK 3.38B 231M
Insulet PODD:US USD 188.3M 2M
Integra Lifesciences IART:US USD 240.94M 13.6M
Masimo MASI:US USD 282.5M 24.3M
Nuvasive NUVA:US USD 214.41M 10.28M
Philips PHIA:NA EUR 1.73B 2M
Resmed RMD:US USD 540.81M 18.3M
Smith & Nephew PLC SN/:LN 1.83B 49M
Steris STE:US USD 532.33M 14.54M
Stryker SYK:US USD 2.8B 41M
Tandem Diabetes Care TNDM:US USD 104.42M 2.48M
Teleflex TFX:US USD 373.96M 14.88M
Terumo 4543:JP JPY 105.36B 3.72B
William Demant Holding WDH:DC DKK 7.08B 13M